Research Article
The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study
Table 2
Univariate Cox regression analysis (n = 109).
| Variables | HR (95% CI) | value |
| Gender (female) | 1.251 (0.770–2.033) | 0.365 | Age (>65) | 1.330 (0.847–2.088) | 0.215 | Residual tumor stage (R1/R2) | 1.118 (0.664–1.882) | 0.674 | Pathological grading (middle) | 1.420 (0.746–2.701) | 0.286 | Pathological grading (high) | 1.942 (0.964–3.911) | 0.063 | TNM staging (III/IV) | 1.399 (1.005–1.946) | 0.040 | Jaundice | 1.063 (0.609–1.855) | 0.800 | CA19-9 | 2.387 (1.413–4.033) | 0.001 | CTR | 3.223 (1.766–5.882) | <0.001 |
|
|
CTR: CA19-9/TBIL ratio.
|